A double-blind study of the peripheral vasoconstrictor effects of the beta-blocking drug penbutolol in patients with Raynaud's phenomenon
- 1 January 1979
- journal article
- clinical trial
- Published by Informa Healthcare in Current Medical Research and Opinion
- Vol. 6 (4) , 267-270
- https://doi.org/10.1185/03007997909109435
Abstract
A double-blind, placebo-controlled study was carried out in 10 hypertensive patients who were subject to frequent attacks of Raynaud's phenomenon and suffered from cold hands, to assess the peripheral vasoconstrictor effects of penbutolol. After a wash-out period of 2 weeks on placebo, patients received two 14-day treatment periods, in random order, with either 20 mg penbutolol twice daily or placebo separated by a second 2-week single-blind wash-out period on placebo. The results of digital blood flow measurements showed that penbutolol did not produce any additional vasoconstrictor effect on digital circulation. The significance of these findings is discussed.Keywords
This publication has 6 references indexed in Scilit:
- Effects of propranolol and metoprolol on the peripheral circulation.BMJ, 1978
- Estimation of the nutrient skin blood flow using a segmented thermal clearance probeClinical and Experimental Dermatology, 1978
- Experimentally Controlled Evaluation of Vasoactive Drugs in Digital IschemiaAngiology, 1978
- Comparative beta‐adrenoceptor blocking effects and pharmacokinetics of penbutolol and propranolol in man.British Journal of Clinical Pharmacology, 1977
- A Double-Blind Trial of Penbutolol: A New Beta-Receptor Blocking Agent in the Treatment of Angina PectorisJournal of International Medical Research, 1976
- Raynaud's phenomenon as side effect of beta-blockers in hypertension.BMJ, 1976